References
- Fuchs A. R. Oxytocin: Clinical and Laboratory Studies, J. Amico, A.G. Robinson. Elsevier Science Publishers, New York, NY 1985; 207–235
- McCarthy M. M., Kleopoulos S. P., Mobbs C. V., Plaff D. W. Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor-binding in the female rat. Neuroendocrinology 1994; 59: 432–440
- Fuchs A. R., Fuchs F., Husslein P., Soloff M. S. Oxytocin receptors in the human uterus during pregnancy and parturition. Am. J. Obstet. Gynecol. 1984; 150: 734–741
- Owen J., Hauth J. C. Oxytocin for the induction or augmentation of labor. Clin. Obstet. Gynecol. 1992; 35: 464–475
- Keirse M. J. New perspectives for the effective treatment of preterm labor. Am. J. Obstet. Gynecol. 1995; 173: 618–628
- Pettibone D. J., Clineschmidt B. V., Guidotti M. T., Lis E. V., Reiss D. R., Woyden C. J., Bock M. G., Evans B. E., Freidinger R. M., Hobbs D. W., Veber D. F., Williams P. D., Chiu S.-H.L., Thompson K. L., Schorn T. W., Siegl P. K., Kaufman M.S. J., Cukierski M. A., Haluska G. J., Cook M. J., Novy M.J. L-368,899 a potent orally active oxytocin antagonist for potential use in preterm labor. Drug Dev. Res. 1993; 30: 129–142
- Kimura T., Tanizawa O., Mori K., Brownstein M. J., Okayama H. Structure and expression of a human oxytocin receptor. Nature 1992; 356: 526–529
- Jasper J. R., Harrell C. M., O'Brien J. A., Pettibone D. J. Characterization of the human oxytocin receptor stably expressed in 293 human embryonic kidney cells. Life Sci. 1995; 57: 2253–2261
- Pettibone D. J., Woyden C. J., Totaro J. A. Identification of functional oxytocin receptors in lactating rat mammary gland in vitro. Eur. J. Pharmacol. 1990; 188: 235–242
- Cheng Y. C., Prusoff W. H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic action. Biochem. Pharmacol. 1973; 22: 3099–3108
- Gorbulev V., Buchner H., Akhundova A., Fahrenholz F. Molecular cloning and functional characterization of V2 [8-Lysine] vasopressin and oxytocin receptors from a pig kidney cell line. Eur. J. Biochem. 1993; 215: 1–7
- Rozen F., Russo C., Banville D., Zingg H. H. Structure, characterization, and expression of the rat oxytocin receptor gene. Proc. Natl. Acad. Sci. USA 1995; 92: 200–204
- Bathgate R., Rust W., Balvers M., Hartung S., Morley S., Ivell R. Structure and expression of the bovine oxytocin receptor gene. DNA Cell Bio. 1995; 14: 1037–1048
- Flint A. P., Riley P. R., Kaluz S., Stewart H. J., Abayasekara D. R. The sheep endometrial oxytocin receptor. Adv. Exp. Med. Biol. 1995; 395: 281–294
- Salvatore C. A., Jacobson M. A., Taylor H. E., Linden J., Johnson R. G. Molecular cloning and characterization of the human A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 1993; 90: 10365–10369
- Liggett S. B. Functional properties of the rat and human β3-adrenergic receptors: Differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol. Pharmacol. 1992; 42: 634–637
- Link R., Daunt D., Barsh G., Chruscinski A., Kobilka B. Cloning of two mouse genes encoding α 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse α2-C10 homology responsible for an interspecies variation in antagonist binding. Mol. Pharmacol. 1992; 42: 16–27
- Pettibone D. J., Kishel M. T., Woyden C. J., Clineschmidt B. V., Bock M. G., Freidinger R. M., Veber D. F., Williams P. D. Radioligand binding studies reveal marked species differences in the vasopressin V1receptor of rat, rhesus and human tissues. Life Sci. 1992; 50: 1953–1958